{"database": "lobbying", "table": "lobbying_activities", "rows": [[1725603, "d25f517f-5613-4316-90c3-92651ad3ead8", "3T", "RED+BLUE STRATEGIES", 400693064, "HOSPIRA", 2015, "third_quarter", "MMM", "Working to ensure that issues related to coding and reimbursement are discussed and addressed to ensure a smooth start to the coverage of biosimilar medications as they enter into the United States' prescription drug market this year.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2015-09-09T15:21:43.843000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1725603"], "units": {}, "query_ms": 0.2005979185923934, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}